Fig. 1From: A robust multiplex immunoaffinity mass spectrometry assay (PromarkerD) for clinical prediction of diabetic kidney diseaseOptimised workflow for immunoaffinity assay for detection of three biomarkers simultaneously in plasmaBack to article page